The AIP Helps Predict CVD

The Atherogenic Index of Plasma (AIP) is a clinical tool that evaluates the risk of cardiovascular diseases by measuring the logarithm of the triglyceride to HDL cholesterol ratio.

This ratio helps assess the presence of small dense LDL cholesterol, which is more prone to cause atherosclerosis because it can easily penetrate arterial walls and undergo oxidation.

A higher AIP is linked to a greater risk of cardiovascular events, including acute myocardial infarction, and is also associated with conditions such as non-alcoholic fatty liver disease.

Effective management of AIP involves lifestyle and dietary modifications that can significantly improve both triglyceride and HDL cholesterol levels, thereby potentially reducing cardiovascular risk.

Source: Puwadon Sang-ngern Pexels.com

Want to Learn More? 

CLICK HERE to learn more about the AIP, health consequences, the ODX ranges, etc.